News
For specialists
Teaching – Research – Interdisciplinary collaboration
For excellent, comprehensive care for patients with vasculitis.
Vasculitis is a complex systemic disease that requires interdisciplinary collaboration. VASAS brings together specialists from clinics and research institutions to share knowledge, advance research and improve and ensure patient care in the long term.
Your benefits as a member:
- Continuing and advanced training: Topic-specific training and advanced training courses with a focus on current developments and new therapies
- Interactive case discussions: monthly, web-based case conferences for professional exchange and discussion of complex and instructive cases
- Scientific networking: annual scientific VASAS Day for clinical and scientific exchange
- Research & registry work: Participation in studies and registries such as the multicenter Takayasu arteritis study and the establishment of the ANCA registry
- Co-designing standards: Development of practical recommendations on diagnostics, therapy and disease monitoring
- Support in everyday life: Help with applications for reimbursement of costs, access to standardized templates and personal collegial advice
- Exclusive member area: Access to materials, tools, study protocols and more
Discussion of cases
Regular web-based case discussions
Every 4-6 weeks
Wednesdays at 5 pm
Added value as a VASAS member
Become part of a dedicated network
for sound decision-making, lively exchange in the fields of research and clinical practice, and interdisciplinary cooperation to ensure optimal care for your patients.
Publications on vasculitis by members of the VASAS - 2024 / 25
- Christ L, Bonel HM, Cullmann JL, Seitz L, Bütikofer L, Wagner F, Villiger PM. Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab. Rheumatology (Oxford). 2025 Apr 1;64(4):2059-2067. doi: 10.1093/rheumatology/keae378. PMID: 39037916.
- Mattioli I, Urban ML, Padoan R, Mohammad AJ, Salvarani C, Baldini C, Berti A, Cameli P, Caminati M, Cathébras P, Bianchi FC, Cinetto F, Cohen Tervaert JW, Coppola A, Costanzo G, Cottin V, Crimi C, Del Giacco S, Desaintjean C, Egan A, Espigol-Frigolé G, Folci M, Fornaro M, Franceschini F, Govoni M, Groh M, Guarnieri G, Hellmich B, Iannone F, Jones R, Kernder A, Lo Gullo A, Lombardi C, Lopalco G, Losappio L, Marchi MR, Rivera CM, Marvisi C, Maule M, Moi L, Monti S, Moosig F, Moroncini G, Negrini SM, Neumann T, Nolasco S, Novikov P, Roccatello D, Samson M, Schroeder JW, Seeliger B, Sinico RA, Solans R, Tcherakian C, Toniati P, Treppo E, Trivioli G, Vacca A, Jayne D, Bettiol A, Vaglio A, Emmi G; European EGPA Study Group. Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study. J Autoimmun. 2025 Mar 26;153:103398. doi: 10.1016/j.jaut.2025.103398. Epub ahead of print. PMID: 40147217.
- Schremmer T, Dejaco C, Recker F, Aschwanden M, Boumans D, Bruyn GA, Chrysidis S, Daikeler T, Nielsen B, De Miguel E, Diamantopoulos AP, Dohn UM, Duftner C, Germano G, Haagsma C, Hartung W, Hocevar A, Iagnocco A, Juche A, Karakostas P, Karalilova R, Keller KK, Sarker B, Smith K, Tischler V, Macchioni P, Milchert M, Monti S, Mukhtyar C, Naredo E, Schmidt WA, Seitz L, Terslev L, Wakefield RJ, Schäfer VS. OMERACT GCA phantom project: validation of a 3D-printed ultrasound training phantom for diagnosis of giant cell arteritis. RMD Open. 2025 Feb 6;11(1):e005316. doi: 10.1136/rmdopen-2024-005316. PMID: 39915246; PMCID: PMC11804187.
- Seitz P, Cullmann J, Bucher S, Bütikofer L, Reichenbach S, Lötscher F, Amsler J, Christ L, Bonel HM, Villiger PM, Seitz L. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica. Rheumatology (Oxford). 2025 Jan 1;64(1):321-331. doi: 10.1093/rheumatology/keae043. PMID: 38265241.
- Pernet M, Moi L, Serra F, Garin N. Oral and Intestinal Manifestations of Giant Cell Arteritis. Eur J Case Rep Intern Med. 2025 Jan 7;12(2):005081. doi: 10.12890/2025_005081. PMID: 39926577; PMCID: PMC11801502.
- Pesce E, Bombaci M, Croci S, Bonacini M, Marvisi C, Ricordi C, Monti S, Muratore F, Abrignani S, Caporali R, Borghi MO, Salvarani C, Villiger PM, Grifantini R, Meroni PL. Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis. Clin Exp Rheumatol. 2024 Jul;42(7):1317-1320. doi: 10.55563/clinexprheumatol/0213qf. Epub 2024 Jun 28. PMID: 38976303.
- Zingg F, Ryser FS, Gloor AD, Polysopoulos C, Villiger PM, Maurer B, Christ L. Serum protein profiling reveals distinct patient clusters in giant cell arteritis. Rheumatology (Oxford). 2024 Oct 1;63(10):2887-2896. doi: 10.1093/rheumatology/keae072. PMID: 38323660.
- Seitz P, Cullmann J, Bucher S, Bütikofer L, Reichenbach S, Lötscher F, Amsler J, Christ L, Bonel HM, Villiger PM, Seitz L. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica. Rheumatology (Oxford). 2025 Jan 1;64(1):321-331. doi: 10.1093/rheumatology/keae043. PMID: 38265241.
- Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. PMID: 38393328.
- Arnold S, Wallmeier P, Tais A, Ihorst G, Janoschke M, Schubach F, Aries P, Bergner R, Bremer JP, Görl N, Gutdeutsch E, Hellmich B, Henes J, Hoyer BF, Kangowski A, Kötter I, Krusche M, Magnus T, Metzler C, Müller-Ladner U, Petersen J, Reichelt de Tenorio A, Schaier M, Schirmer JH, Schönermarck U, Thiel J, Unger L, Venhoff N, Weinmann-Menke J, Iking-Konert C, Lamprecht P. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patients. Clin Exp Rheumatol. 2024 Apr;42(4):852-858. doi: 10.55563/clinexprheumatol/suxkyq. Epub 2024 Apr 12. PMID: 38607682.
- Wallmeier P, Arnold S, Tais A, Ihorst G, Janoschke M, Schubach F, Aries P, Bergner R, Bremer JP, Görl N, Gutdeutsch E, Hellmich B, Henes J, Hoyer BF, Kangowski A, Kötter I, Krusche M, Magnus T, Metzler C, Müller-Ladner U, Schaier M, Schönermarck U, Thiel J, Unger L, Venhoff N, Weinmann-Menke J, Petersen J, Lamprecht P, Iking-Konert C. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients. Clin Exp Rheumatol. 2024 Apr;42(4):895-904. doi: 10.55563/clinexprheumatol/d3o0gu. Epub 2024 Apr 19. PMID: 38683207.
- Hoffmann A, Almiri W, Mordasini P, Bähler A, Seiffge DJ, Göldlin MB, Jäger E, Muresan IP, Christ L, Heldner MR, Wiest R, Radojewski P. 7T MRI as a powerful tool to detect small and medium size vessel CNS vasculitis. AJNR Am J Neuroradiol. 2024 Dec 18:ajnr.A8627. doi: 10.3174/ajnr.A8627. Epub ahead of print. PMID: 39694614.
- Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R, Terrier B. Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors. J Autoimmun. 2024 Dec;149:103338. doi: 10.1016/j.jaut.2024.103338. Epub 2024 Nov 16. PMID: 39549485.
- Sachez-Alamo B, Moi L, Bajema I, Berden A, Flossmann O, Hruskova Z, Jayne D, Wester-Trejo M, Wallquist C, Westman K. Long-term outcome of kidney function in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2024 Aug 30;39(9):1483-1493. doi: 10.1093/ndt/gfae018. Erratum in: Nephrol Dial Transplant. 2024 Sep 19:gfae201. doi: 10.1093/ndt/gfae201. PMID: 38268409; PMCID: PMC11361807.
- Bettiol A, Urban ML, Padoan R, Groh M, Lopalco G, Egan A, Cottin V, Fraticelli P, Crimi C, Del Giacco S, Losappio L, Moi L, Cinetto F, Caminati M, Novikov P, Berti A, Cameli P, Cathébras P, Coppola A, Durel CA, Folci M, Lo Gullo A, Lombardi C, Monti S, Parronchi P, Rivera CM, Solans R, Vacca A, Espígol-Frigolé G, Guarnieri G, Bianchi FC, Marchi MR, Tcherakian C, Kahn JE, Iannone F, Venerito V, Desaintjean C, Moroncini G, Nolasco S, Costanzo GAML, Schroeder JW, Ribi C, Tesi M, Gelain E, Mattioli I, Bello F, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study. Lancet Rheumatol. 2023 Dec;5(12):e707-e715. doi: 10.1016/S2665-9913(23)00243-6. Epub 2023 Nov 6. PMID: 38251561.
- Krämer S, Vogt K, Schreibing TM, Busch M, Schmitt T, Bergner R, Mosberger S, Neumann T, Rauen T. Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohort. Rheumatol Int. 2024 Dec 24;45(1):7. doi: 10.1007/s00296-024-05757-4. PMID: 39718586; PMCID: PMC11668861.
- Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R, Terrier B. Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors. J Autoimmun. 2024 Dec;149:103338. doi: 10.1016/j.jaut.2024.103338. Epub 2024 Nov 16. PMID: 39549485.
- Joos L, Gonzalez Chiappe S, Neumann T, Mahr A. Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners. Rheumatol Int. 2024 Dec;44(12):3099-3106. doi: 10.1007/s00296-024-05620-6. Epub 2024 Jun 27. PMID: 38935122.
- Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie SL, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford CA, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Daikeler T, Berger CT, Molloy ES, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel PA, Cid MC, González-Gay MA, Morgan AW, Martin J, Márquez A; Spanish GCA Group; UK GCA Consortium; Vasculitis Clinical Research Consortium. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. Lancet Rheumatol. 2024 Jun;6(6):e374-e383. doi: 10.1016/S2665-9913(24)00064-X. Epub 2024 May 8. PMID: 38734017; PMCID: PMC11108802.
- Geraldes R, Santos M, Ponte C, Craven A, Barra L, Robson JC, Hammam N, Springer J, Henes J, Hocevar A, Putaala J, Santos E, Rajasekhar L, Daikeler T, Karadag O, Costa A, Khalidi N, Pagnoux C, Canhão P, Melo TPE, Fonseca AC, Ferro JM, Fonseca JE, Suppiah R, Watts RA, Grayson P, Merkel PA, Luqmani RA; DCVAS Study Group. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study. J Neurol. 2024 Jun;271(6):3309-3320. doi: 10.1007/s00415-024-12251-1. Epub 2024 Mar 12. PMID: 38472397; PMCID: PMC11136713.
- Hemmig AK, Rottenburger C, Baruti L, Mensch N, Aschwanden M, Kyburz D, Pradella M, Staub D, Stegert M, Berger CT, Imfeld S, Sommer G, Daikeler T. Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis - A cohort study. Semin Arthritis Rheum. 2024 Jun;66:152425. doi: 10.1016/j.semarthrit.2024.152425. Epub 2024 Feb 28. PMID: 38442463.
- Borrego-Yaniz, Ortiz-Fernández, Madrid-Paredes, Kerick, Hernández-Rodríguez, Mackie, Vaglio, Castañeda, Solans, Mestre, Khalidi, Langford, Ytterberg, Beretta, Govoni, Emmi, Cimmino, Witte, Neumann, Holle, Schönau, Puignet, Papo, Haroche, Mahr, Mouthon, Molberg, Diamantopoulos, Voskuyl, Daikeler, Berger, Molloy, Blockmans, Iles, Sorensen, Luqmani, Reynolds, Bukhari, Bhagat, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium, Ortego-Centeno, Brouwer, Lamprecht, Kapla, Salvarani, Merkel, Cid, González-Gay, Morgan, Martin, Marquez, Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study, Lancet Rheumatology, Volume 6, Issue 6, June 2024, Pages e374-e383
- Joos L, Gonzalez Chiappe S, Neumann T, Mahr A, Use of Mesna Prophylaxis in Patients with Cyclophosphamide-Treated ANCA-associated Vasculitis: Cross-Sectional Survey of Practitioners, Rheumatology International 2024
- Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R and Terrier B, on behalf of the French Vasculitis Study Group (FVSG) and the European EGPA Study Group (EESG), Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis, factor: a target trial emulation study, J Autoimmun. 2024
